Patents by Inventor Thomas Paterson

Thomas Paterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050130192
    Abstract: Apparatus and method for identifying therapeutic targets of a biological system in a disease state are described. In one implementation, a method uses a computer model of the biological system. The method includes identifying a set of functions of a biological constituent of the biological system. The method also includes executing the computer model in the absence of a modification of the set of functions to produce a first output and executing the computer model based on the modification of the set of functions to produce a second output. The method further includes comparing the second output with the first output to identify the biological constituent as a therapeutic target.
    Type: Application
    Filed: September 10, 2004
    Publication date: June 16, 2005
    Inventors: Thomas Paterson, Leif Wennerberg
  • Patent number: 4252946
    Abstract: 8-Substituted pyrido[2,3-d]pyrimidines having activity against microorganisms which utilize de novo synthesis of riboflavin.
    Type: Grant
    Filed: March 30, 1978
    Date of Patent: February 24, 1981
    Assignee: Burroughs Wellcome Co.
    Inventors: Hamish C. S. Wood, Thomas Paterson
  • Patent number: 4116958
    Abstract: A method of preparation of 2,4-diamino-5-benzylpyrimidines involving the reaction of a 2,4-diamino-5-substituted methyl pyrimidine, for example 2,4-diamino-5-hydroxymethylpyrimidine, with an appropriately substituted phenol.
    Type: Grant
    Filed: October 10, 1972
    Date of Patent: September 26, 1978
    Assignee: Burroughs Wellcome Co.
    Inventors: Alexander Stuart, Thomas Paterson
  • Patent number: 4113859
    Abstract: 8-Substituted pyrido [2,3-d]pyrimidines having activity against microorganisms which utilize de novo synthesis of riboflavin.
    Type: Grant
    Filed: February 23, 1973
    Date of Patent: September 12, 1978
    Assignee: Burroughs Wellcome Co.
    Inventors: Hamish Christopher Swan Wood, Thomas Paterson